Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Professor Rajesh Thakker receives prestigious William F. Neuman Award

Professor Rajesh Thakker has been named the 2026 recipient of the William F. Neuman Award from the American Society for Bone and Mineral Research (ASBMR), recognising his outstanding scientific contributions to the field.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Professor Jan Rehwinkel receives funding to tackle viral threats

A research project led by Professor Jan Rehwinkel is one of three innovative Oxford-led projects aimed at transforming how we protect against respiratory viruses, which have secured funding through the UK’s Advanced Research and Invention Agency (ARIA).

Professor KJ Patel awarded major European Research Council Advanced Grant

Professor Patel is one of fourteen researchers at the University of Oxford awarded Advanced Grants from the European Research Council (ERC), each worth up to €2.5 million over a period of five years.

AI tool reveals hidden organ damage caused by high blood pressure

Researchers at the University of Oxford have developed an artificial intelligence (AI) tool that may help doctors better understand how high blood pressure damages different organs in different people - potentially paving the way for more personalised treatment in future.

New studies shed light on how best to guide heart artery procedures

Three clinical trials have shed new light on which approaches are most useful when treating narrowed heart arteries. They challenge the current guidance on how to insert stents.

Study reveals blood stem cells can ‘remember’ inflammation

Researchers have discovered that some human blood stem cells retain a lasting “memory” of inflammation, a finding that could help explain links between ageing, chronic disease, and blood cancers

Reversing T cell exhaustion improves effectiveness of myeloma immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai, Bristol Myers Squibb (BMS), and the University of Oxford have discovered a way to give worn-out immune cells a second wind in the fight against multiple myeloma.

New AI model predicts how cells choose their fate

Researchers from the University of Oxford, the Stowers Institute for Medical Research, Helmholtz Munich, and the Technical University of Munich have developed a new artificial intelligence framework that helps uncover how cells make developmental decisions.

Heart scan and blood test improve risk prediction for inherited heart condition, major study finds

A large international study led by researchers at the University of Oxford and the University of Virginia (USA) has identified a new model for predicting outcomes for hypertrophic cardiomyopathy (HCM) – a heart condition that is the most frequent cause of sudden cardiac death in younger individuals.

Deputy Directors of the MRC Weatherall Institute of Molecular Medicine

Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.

Congratulations to our new Associate Professors

RDM is delighted to announce that the title of Associate Professor has been conferred on four of our researchers. Each of our new Associate Professors has been awarded the title in recognition of their contributions to research, teaching and citizenship at the University and beyond.

Naveed Akbar awarded International Cardiovascular Research Partnership funding

Leading mid-career scientists from the UK, France, Germany, and the Netherlands have received almost €6 million from a pioneering partnership between the British Heart Foundation (BHF), the Dutch Heart Foundation (DHF), the German Centre for Cardiovascular Research (DZHK) and the Lefoulon Delalande Foundation (LDF), to support vital international research collaborations work over four years.

Research uncovers new mechanism controlling inflammation in immune cells

Researchers from the University of Oxford's Radcliffe Department of Medicine and the University of Surrey have discovered that a key immune enzyme controls inflammation in a way that does not depend on its well-known function.

Kevin Rue-Albrecht to lead BioFAIR Pathfinder Project

Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.

Pramila Rijal awarded grant from Academy of Medical Sciences Springboard Programme

Now in its 11th year, Springboard supports researchers at a critical point in their careers, when many are establishing laboratories for the first time and need the freedom to explore ambitious questions.

Load More